Gene, Cell and Tissue

Published by: Kowsar

RNASEL R462Q Mutation in Prostate Cancer

Xiuping Yu 1 , Robert J. Matusik 2 and Renjie Jin 2 , *
Authors Information
1 Health Sciences Center, Louisiana State University, Shreveport, USA
2 Department of Urologic Surgery and Vanderbilt Prostate Cancer Center, Vanderbilt University Medical Center, Nashville, USA
Article information
  • Gene, Cell and Tissue: November 2014, 2 (1); e60170
  • Published Online: November 25, 2014
  • Article Type: Letter
  • Received: October 8, 2014
  • Revised: October 21, 2014
  • Accepted: October 28, 2014
  • DOI: 10.17795/gct-24411

To Cite: Yu X, Matusik R J, Jin R. RNASEL R462Q Mutation in Prostate Cancer, Gene Cell Tissue. 2014 ; 2(1):e60170. doi: 10.17795/gct-24411.

Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Thompson D, Easton DF, Breast Cancer Linkage C. Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 2002; 94(18): 1358-65[PubMed]
  • 2. Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol. 2004; 22(4): 735-42[DOI][PubMed]
  • 3. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, et al. Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med. 2012; 366(2): 141-9[DOI][PubMed]
  • 4. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet. 2002; 30(2): 181-4[DOI][PubMed]
  • 5. Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. Mutation in Prostate Cancer Specimens Gene Cell Tissue. 2014; 1(2)
  • 6. Brennan-Laun SE, Ezelle HJ, Li XL, Hassel BA. RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting. J Interferon Cytokine Res. 2014; 34(4): 275-88[DOI][PubMed]
  • 7. Karyadi DM, Zhao S, He Q, McIntosh L, Wright JL, Ostrander EA, et al. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. Int J Cancer. 2014; [DOI][PubMed]
  • 8. Bettoun DJ, Scafonas A, Rutledge SJ, Hodor P, Chen O, Gambone C, et al. Interaction between the androgen receptor and RNase L mediates a cross-talk between the interferon and androgen signaling pathways. J Biol Chem. 2005; 280(47): 38898-901[DOI][PubMed]
  • 9. Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, et al. A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res. 2013; 19(6): 1612-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments